COVID-19 환자에서 나타나는 섬망에 대한 고찰

• 영문명: A Short Review of Delirium in Patients With COVID-19
• 발행기관: 대한노인정신의학회
• 저자명: 한명일(Myeong-Il Han) 김용(Yong Kim) 김철응(Choel Eung Kim) 최말례(Mal-Rye Choi)
• 간행물 정보: 『노인정신의학』노인정신의학 제25권 제2호, 65~69쪽, 전체 5쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2021.10.30

영문 초록

We reviewed the clinical features, prevalence, pathophysiology, and prevention and treatment of delirium in patients with coronavirus disease of 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, has neurotropic properties, and can penetrate the central nervous system and affect brain neurons. These characteristics may explain the fact that COVID-19 patients may be particularly susceptible to delirium. COVID-19 delirium occurred more frequently in intensive care unit and emergency room settings. Patients with neurologic disorders and the elderly were more vulnerable to delirium. Clinical symptoms of COVID-19 delirium may manifest as a hyper/hypoactive type. Prevention and treatment appear to be similar to conventional treatment strategies. And the patient’s feeling of isolation due to social distancing and a highly intensive labor force of medical personnel must be overcome. Melatonin, alpha-2 agonist, antipsychotics, and valproic acid have been recommended for the treatment of delirium symptoms. However, this article did not go through a systematic literature review.

목차

서론

COVID-19에서의 섬망, 유병률, 그리고 임상 양상

COVID-19 섬망의 병태생리

COVID-19에서 섬망의 예방과 치료

결론

키워드

섬망 코로나-19 코로나바이러스 노인 정신착란 Delirium COVID-19 SARS-CoV-2 Aged Confusion